Vaccine Supply
Malawi runs out of coronavirus vaccines as second jabs due
Delays in coronavirus vaccine shipments to Malawi have caused health facilities to run out of doses as hundreds are due to receive a second shot, the health minister said Saturday. The southern African country has so far received 300 000 doses of the AstraZeneca vaccine from the United Nations, 102 000 from the African Union and 50 000 donated by India. Inoculations started in April and the country was expecting a second UN shipment of 900 000 by the end of May, four weeks before the first vaccinated Malawians would be due a second dose. But Health Minister Khumbize Kandodo said that batch had been delayed by a recent surge in coronavirus cases in India, the world’s main AstraZeneca supplier, which forced the country to temporarily halt major vaccine exports to meet local demand. “The situ...
US workers enticed with bonuses, time off to get coronavirus vaccine
As Covid-19 vaccination drives get into gear across the United States, some businesses are offering transportation, paid time off and bonuses of up to $500 to encourage workers to get the jab. Labor-intensive industries like slaughterhouses, supermarkets, and farms, whose workers are at higher risk of contracting the virus, have taken the lead, with several large grocery chains offering two to four hours of paid leave time for employees to get vaccinated. “Providing accommodations so employees can receive this critical vaccine is one more way we can support them and eliminate the need to choose between earning their wages and protecting their well-being,” Jason Hart, CEO of supermarket chain Aldi, said in January. Others have taken advantage of Centers for Disease Control and Prevention re...
Coronavirus vaccine breakthrough raises hopes of rapid global rollout
A coronavirus vaccine developed by Britain’s University of Oxford and the pharmaceutical firm AstraZeneca has shown successful results in early trials. If it is approved by regulators, the vaccine appears suitable for a fast rollout around the globe. Early analysis of trials involving 20,000 volunteers in Britain and Brazil show the vaccine is at least 62% effective after two doses. In volunteers given a different dosing regimen — a half dose, followed by a full dose — that figure rose to 90%. The average efficacy of the two dosing methods is 70%. None of those given the vaccine developed severe COVID-19 illness. Andrew Pollard, director of the Oxford Vaccine Group, said the recent successful trials of three different vaccines by Oxford-AstraZeneca, Pfizer-BioNTech and Moderna, represent a...
Taiwan says request to drop word ‘country’ preceded BioNTech vaccine deal collapse
Germany’s BioNTech asked Taiwan to remove the word “country” from an announcement they planned to make on a COVID-19 vaccine sale to the island, its health minister said on Thursday, giving details of the deal whose axing was blamed on China by Taipei. Taiwan and China are engaged in an escalating war of words after Beijing offered the shots to the Chinese-claimed island via Shanghai Fosun Pharmaceutical Group Co Ltd, which has a contract to sell them in Greater China. Taiwan Health Minister Chen Shih-chung told a daily news briefing the government had signed and sent back a “final contract” agreed with BioNTech after months of negotiations, and the two sides were on the verge of issuing a press release on Jan. 8. But four hours later “BioNTech suddenly sent a letter, saying they strongly ...